June 03, 2026
2 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Semaglutide confers similar weight, cardiovascular benefits across all menopausal stages
Once-weekly injectable semaglutide is tied to weight loss and cardiovascular benefits for women regardless of menopause status, according to data from two post hoc analyses presented at the European Congress on Obesity.“Menopause is more than hot flushes; it’s a cardiometabolic transition,” Emilia Huvinen, MD, PhD, associate professor and specialist in obstetrics and gynecology
838 words~4 min read
